The global treatment landscape for malaria and sickle cell disease reflects significant regional disparities driven by disease prevalence, healthcare accessibility, and economic conditions. These two conditions continue to impose a heavy burden on public health systems, particularly in developing regions where early diagnosis and advanced treatment options are often limited. Differences in...